norethindrone has been researched along with Bone Loss, Osteoclastic in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (37.50) | 18.7374 |
| 1990's | 7 (29.17) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DiVasta, AD; Feldman, HA; Gordon, CM; Hornstein, MD; Laufer, MR; Sadler Gallagher, J; Stokes, NA | 1 |
| Carlsten, H; d'Elia, HF; Pullerits, R; Tarkowski, A | 1 |
| Abrahamsen, B; Beck-Nielsen, H; Bonnevie-Nielsen, V; Rettmer, E; Stilgren, LS | 1 |
| Adamo, EB; Altavilla, D; Bartolone, S; Bitto, A; Corrado, F; Crisafulli, A; D'Anna, R; Frisina, N; Inferrera, MA; Marini, H; Marini, R; Romeo, A; Squadrito, F; Squadrito, G | 1 |
| Constant, D; Cooper, D; Hoffman, M; Kalla, AA; Micklesfield, L; Rosenberg, L; Zhang, Y | 1 |
| Delmas, PD; Hall, GM; Spector, TD | 1 |
| Baylink, DJ; Demarest, KT; Lau, KH; Linkhart, TA; Wang, SP | 1 |
| Bailey, MC; Bain, SD; Celino, DL; Edwards, MW; Jensen, E; Lantry, MM | 1 |
| Fournet, N; Judd, HL; Surrey, ES; Voigt, B | 1 |
| Alexandersen, P; Christiansen, C; Riis, BJ | 1 |
| Horowitz, M; Morris, HA; Need, AG; Nordin, BE; Scopacasa, F | 1 |
| Alatalo, SL; Cheng, S; Halleen, JM; Janckila, AJ; Suominen, H; Väänänen, HK | 1 |
| Bröll, H; Griesmacher, A; Kumpan, W; Marteau, R; Müller, MM; Peichl, P | 1 |
| Bernard-Poenaru, O; Blanqué, R; Cohen-Solal, ME; de Vemejoul, MC; Gardner, C; Roux, C | 1 |
| Gallagher, JC; Guha, P; Hanes, F; Marshall, DH; Nordin, BE; Oldfield, W | 1 |
| Goldsmith, NF; Johnston, JO | 1 |
| Jacobson, JB | 1 |
| Kanka, J; Mensík, J; Pacovský, V; Pospíchal, J; Presl, J; Schreiber, V; Stĕpán, JJ | 1 |
| Christiansen, C; Deftos, L; Nilas, L; Riis, BJ; Rødbro, P | 1 |
| Anderson, C; Karambolova, KK; Snow, GR | 1 |
| Christiansen, C; Larsen, NE; Pødenphant, J; Riis, BJ | 1 |
| Peacock, M; Selby, PL | 1 |
| Barkworth, SA; Brown, WB; Peacock, M; Selby, PL; Taylor, GA | 1 |
| Christiansen, C; Jensen, J; Rødbro, P | 1 |
12 trial(s) available for norethindrone and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial.
Topics: Absorptiometry, Photon; Adolescent; Bone Density; Bone Resorption; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Endometriosis; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Norethindrone; Norethindrone Acetate; Prospective Studies; Quality of Life; Risk Assessment; Treatment Outcome; Young Adult | 2015 |
The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial.
Topics: Alkaline Phosphatase; Arthritis, Rheumatoid; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Calcium; Cartilage; Cartilage Oligomeric Matrix Protein; Cholecalciferol; Estradiol; Estrogen Replacement Therapy; Extracellular Matrix Proteins; Female; Glycoproteins; Humans; Matrilin Proteins; Middle Aged; Norethindrone; Norethindrone Acetate; Peptide Fragments; Postmenopause; Procollagen; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Statistics, Nonparametric | 2009 |
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin system in early postmenopausal women.
Topics: Amino Acids; Bone Density; Bone Remodeling; Bone Resorption; Carrier Proteins; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Femur Neck; Genistein; Glycoproteins; Humans; Membrane Glycoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoprotegerin; Placebos; Postmenopause; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor | 2004 |
Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy.
Topics: Absorptiometry, Photon; Adrenal Cortex Hormones; Alkaline Phosphatase; Amino Acids; Arthritis, Rheumatoid; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Calcium; Cohort Studies; Dose-Response Relationship, Drug; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Osteocalcin; Postmenopause | 1995 |
Effects of sodium etidronate in combination with low-dose norethindrone in patients administered a long-acting GnRH agonist: a preliminary report.
Topics: Bone Density; Bone Resorption; Drug Therapy, Combination; Endometriosis; Estrogens; Etidronic Acid; Female; Humans; Leuprolide; Lipids; Norethindrone; Prospective Studies; Vasomotor System | 1993 |
Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study.
Topics: Aged; Bone Density; Bone Remodeling; Bone Resorption; Calcium; Double-Blind Method; Drug Synergism; Estradiol; Estrogen Replacement Therapy; Female; Fluorides; Humans; Lipids; Middle Aged; Norethindrone; Norethindrone Acetate; Phosphates; Placebos; Postmenopause; Prospective Studies | 1999 |
Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption.
Topics: Acid Phosphatase; Antibodies, Monoclonal; Biomarkers; Bone Resorption; Double-Blind Method; Enzyme Stability; Estradiol; Estrogen Replacement Therapy; Female; Humans; Isoenzymes; Middle Aged; Neuraminidase; Norethindrone; Placebos; Postmenopause; Reference Values; Tartrate-Resistant Acid Phosphatase | 2000 |
Bone-resorbing cytokines from peripheral blood mononuclear cells after hormone replacement therapy: a longitudinal study.
Topics: Aged; Amino Acids; Bone Resorption; Cells, Cultured; Cytokines; Estradiol; Estrogen Replacement Therapy; Female; Humans; Interleukin-1; Interleukin-6; Leukocytes, Mononuclear; Longitudinal Studies; Middle Aged; Norethindrone; Norethindrone Acetate | 2001 |
The effect of 1alpha-hydroxycholecalciferol and hormone therapy on the calcium balance of post-menopausal osteoporosis.
Topics: Bone and Bones; Bone Regeneration; Bone Resorption; Calcium; Clinical Trials as Topic; Ethinyl Estradiol; Female; Humans; Hydroxycholecalciferols; Hydroxyproline; Intestinal Absorption; Menopause; Norethindrone; Osteoporosis; Surgery, Plastic | 1977 |
Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis.
Topics: Bone Development; Bone Resorption; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estriol; Estrogens; Female; Humans; Menopause; Middle Aged; Norethindrone; Osteoporosis; Progestins | 1985 |
Hydroxyproline/creatinine ratios as estimates of bone resorption in early postmenopausal women. Fasting and 24-h urine samples compared.
Topics: Bone Resorption; Clinical Trials as Topic; Creatinine; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Estrogens; Female; Humans; Hydroxycholecalciferols; Hydroxyproline; Menopause; Middle Aged; Norethindrone | 1986 |
Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.
Topics: Adult; Bone Resorption; Drug Combinations; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menopause; Middle Aged; Norethindrone; Osteoporosis; Smoking | 1985 |
12 other study(ies) available for norethindrone and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Effects of the natural and artificial menstrual cycle on the production of osteoprotegerin and the bone resorptive cytokines IL-1beta and IL-6.
Topics: Adolescent; Adult; Aged; Bone Resorption; Cells, Cultured; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Glycoproteins; Humans; Interleukin-1; Interleukin-6; Menstrual Cycle; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoprotegerin; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor | 2003 |
Bone status after cessation of use of injectable progestin contraceptives.
Topics: Adolescent; Adult; Ambulatory Care Facilities; Black People; Bone Density; Bone Resorption; Calcaneus; Contraceptive Agents, Female; Cross-Sectional Studies; Delayed-Action Preparations; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone; South Africa; Ultrasonography | 2007 |
Picomolar norethindrone in vitro stimulates the cell proliferation and activity of a human osteosarcoma cell line and increases bone collagen synthesis without an effect on bone resorption.
Topics: Animals; Bone and Bones; Bone Development; Bone Resorption; Calcitriol; Cell Differentiation; Cell Division; Chickens; Collagen; DNA; Humans; Mice; Norethindrone; Organ Culture Techniques; Osteoblasts; Osteocalcin; Osteosarcoma; Thymidine; Tumor Cells, Cultured | 1994 |
High-dose gestagens modulate bone resorption and formation and enhance estrogen-induced endosteal bone formation in the ovariectomized mouse.
Topics: Analysis of Variance; Animals; Bone Development; Bone Resorption; Estradiol; Female; Femur; Megestrol; Megestrol Acetate; Mice; Mice, Inbred BALB C; Norethindrone; Norethindrone Acetate; Osteoclasts; Ovariectomy; Progesterone Congeners; Radioimmunoassay; Random Allocation; Spine; Tibia | 1993 |
The effects of low dose norethisterone on biochemical variables in postmenopausal women.
Topics: Aged; Biomarkers; Bone Resorption; Calcium; Cholesterol; Drug Administration Schedule; Female; Humans; Middle Aged; Norethindrone; Osteoporosis, Postmenopausal; Phosphates; Progesterone Congeners | 1999 |
Serum osteocalcin and urinary crosslaps are suitable markers of bone turnover in response to short-term hormone replacement therapy.
Topics: Administration, Oral; Aged; Amino Acids; Biomarkers; Bone Resorption; Collagen; Estrogen Replacement Therapy; Estrogens; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Middle Aged; Norethindrone; Osteocalcin; Osteogenesis; Peptide Fragments; Postmenopause | 2000 |
Bone mineral: effects of oral contraceptives, pregnancy, and lactation.
Topics: Adolescent; Adult; Age Factors; Aged; Bone and Bones; Bone Development; Bone Resorption; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Dimethisterone; Estradiol Congeners; Ethinyl Estradiol; Ethnicity; Ethynodiol Diacetate; Female; Humans; Iodine Radioisotopes; Lactation; Medroxyprogesterone; Mestranol; Middle Aged; Minerals; Norethindrone; Norethynodrel; Norgestrel; Parity; Pregnancy; Radius | 1975 |
Effects of nafarelin on bone density.
Topics: Adult; Bone Density; Bone Resorption; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Nafarelin; Norethindrone | 1990 |
The application of plasma tartrate-resistant acid phosphatase to assess changes in bone resorption in response to artificial menopause and its treatment with estrogen or norethisterone.
Topics: Acid Phosphatase; Adult; Bone Resorption; Drug Resistance; Estrogens; Female; Humans; Menopause; Middle Aged; Norethindrone; Ovariectomy; Tartrates | 1989 |
Surface activity on the periosteal and corticoendosteal envelopes following continuous progestogen supplementation in spayed beagles.
Topics: Animals; Bone and Bones; Bone Resorption; Dogs; Female; Minerals; Norethindrone; Norethindrone Acetate; Osteogenesis; Ovariectomy; Periosteum | 1986 |
Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women.
Topics: Bone Resorption; Calcitriol; Calcium; Ethinyl Estradiol; Female; Humans; Hydroxyproline; Hyperparathyroidism; Menopause; Middle Aged; Norethindrone; Parathyroid Hormone; Time Factors; Vitamin D-Binding Protein | 1986 |
Early effects of ethinyloestradiol and norethisterone treatment in post-menopausal women on bone resorption and calcium regulating hormones.
Topics: Bone Resorption; Calcitonin; Calcitriol; Calcium; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Menopause; Middle Aged; Norethindrone; Parathyroid Hormone; Vitamin D-Binding Protein | 1985 |